Showing results (31-40 of 2,795) with videos related to
Sort By:
Pageof 280
Immunological Reviews|May 12, 2009
Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapyJoseph R Podojil, Stephen D MillerJournal of Autoimmunity|June 24, 2017
Targeting the GM-CSF receptor for the treatment of CNS autoimmunityIgal Ifergan, Todd S Davidson, Hania Kebir, et al.Diabetes Management (London, England)|February 8, 2014
Inducing immune tolerance: a focus on Type 1 diabetes mellitusDan Xu, Suchitra Prasad, Stephen D MillerThe Review of Diabetic Studies : RDS|June 28, 2013
Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetesSuchitra Prasad, Dan Xu, Stephen D MillerFrontiers in Cellular Neuroscience|November 23, 2013
Immune mechanisms in epileptogenesisDan Xu, Stephen D Miller, Sookyong KohImmunological Reviews|December 16, 2011
Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating diseaseEmily M L Chastain, Stephen D MillerBiorxiv : the Preprint Server for Biology|March 3, 2025
Wnt-Activated Immunoregulatory Myeloid Cells Prevent Relapse in Experimental Autoimmune Encephalomyelitis and Offer a Potential Therapeutic Strategy for Multiple SclerosisAnastasia Alkhimovitch, Stephen D Miller, Igal IferganExpert Review of Clinical Immunology|May 19, 2010
T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapiesBettina Schreiner, Samantha L Bailey, Stephen D MillerScientific Reports|May 23, 2012
Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation functionRhoda A Chang, Stephen D Miller, Richard LongneckerJournal of Neuroimmunology|March 7, 2002
Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MSKatherine L Neville, Josette Padilla, Stephen D MillerPageof 280